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The West Nile Virus (WNV)
Flaviviridae – Flavivirus - Japanese encephalitis serocomplex
Lineage 1 Lineage 2
 widespread 
 highly pathogenic, 
neuroinvasive












 Hu: WNV fever
































 Cerebrospinal fluid: high protein +/- pleocytosis 
with lymphocytes or neutrophils
WNV outbreaks
 between August and November
 horses showing neurological symptomes


























IgM Elisa positivity is not a diagnosis!
Scenario: 
 13 years old pony
 neurlogoc signs started in April
 progressive ataxia, dysphagia, pharyngeal, 
laryngeal paralysis
 IgM Elisa positive in July
 Vaccinated 2 years ago?
RESPE
Outcome





Tested Positive Showing 
clinical signs













15 105 47 18 5 44,7 38,3 27,8
Non-affected
premises 3 184 45 0 0 24,4 0 0
Total 18 289 92 18 5 31,8 19,5 27,8
Hungary
 both lineage 1 and 2 strains circulating
 clinical cases by linegae 2 strains
Case distribution
Av2004: avian WNVcases in 2004
Av2005: avian WNVcases in 2005
Ov2005: sheep encephalomyelitis
Av2007: avian WNVcases in 2007
Eq2007:first equine
encephyalomyelitis in 2007
Equine cases in 2008




Lineage 2 strain 
Lineage 1 strains
European Centre for Disease Prevention and 
Control
ECDC data
Human data 2014 AUG-OCT















 Need for persistent serosurvey and virus isolation
Postvaccination IgG, IgM
 Lineage 1 vaccines are protective
The West Nile Virus (WNV)
 zoonotic
 reportable to EU
 in Hungary: IgM ELISA only NFCSO central lab
 test paid by the state
 actions: report exact GPS coordinates, in case of a 
death PCR analysis 
Outbreaks
 non-predictable
 eg. 2012 USA, 286 human deaths in Texas
 Macedonia, Greece: 2010-2011
Thank you for your attention!
